Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Intelligent Bio Solutions Inc. - Common Stock (NQ:INBS)

1.710 +0.010 (+0.59%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Intelligent Bio Solutions Inc. - Common Stock

< Previous 1 2 3 Next >
LargeCap Big Tech Stocks Report Earnings Today: Discover SmallCap Stocks Inside to Watch Now!
Via AB Newswire
5 Stocks in the News to Watch Now: LGVN, PRSO, SIRI, INBS, VTAK
Via AB Newswire
“Intelligent Bio Solutions (Nasdaq: INBS) Expands Influence with Key Client Accounts in UK Manufacturing Sector”
Via AB Newswire
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Revolutionizes Drug Testing Ensuring Workplace Safety; Poised for Global Expansion
Via AB Newswire
Topics Cannabis
July 2024 Hot Small-Cap Stocks Under $5 Gaining Now: KAVL, VTAK, INBS, BSFC, PRSO
Via AB Newswire
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Rises in After-Hours Trading Following Major UK Contracts and FDA Progress
Via AB Newswire
Topics Economy
Nasdaq Stocks Soaring to the Top with Strategic Splits: NVDA, INBS, JAGX, SINT, GWAV
Via AB Newswire
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Advancing US FDA Process, Featured Among Top Health Care Movers
Via AB Newswire
Spotlighting Unexplored Stocks in Focus: NKGN, INBS, BTBT, PRSO, MGOL
Via AB Newswire
Topics Artificial Intelligence
Intelligent Bio Solutions Inc. (NASDAQ: INBS): Research Report Update May 2024
Via AB Newswire
Topics Intellectual Property
Top Stocks to Watch: FFIE, PLUG, SPWR, More Inside!
Via AB Newswire
Market Movers on The Street: LAZR, INBS, REBN, PSRO
Via AB Newswire
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
Via AB Newswire
Discovering Undervalued Stocks in Today’s Market: OCGN, INBS, KAVL, DYAI, VTAK
Via AB Newswire
Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK
Via AB Newswire
Intelligent Bio Solutions Inc. (NASDAQ: INBS): Pioneering Advances in Medical Technology – Full Analysis Inside!
Via AB Newswire
Key Stocks to Watch: Recent News, Developments and Market Potential KAVL, INBS, GEVI, VTAK, RLYB
Via AB Newswire
Topics Intellectual Property
Stocks to Watch for Short Squeeze Potential: DJT, INBS, IMPP, HUBC, XXII
Via AB Newswire
Topics Government
Ladenburg Thalmann, Esteemed Wall Street Long-Standing Stalwart Since 1876, Advocates ‘Buy’ for Intelligent Bio, Precision Bio, and More: VTAK, INBS, LASE, MYMD, RVSN
Via AB Newswire
Reddit Inc. (NYSE: RDDT) Surges, Uncovering Undervalued Opportunities: DYAI, INBS, MESO, VTAK
Via AB Newswire
Topics Initial Public Offering
March Madness 2024: Key Players in Medical Tech, Healthcare and AI: INBS, AMTX, VTAK, ANGH, TRUG
Via AB Newswire
Topics Energy
March Madness Market Movers: INBS, NCMI, CIFR, IMRX, STI
Via AB Newswire
Emerging Companies: Key Developments and Investment Insights RGLS, INBS, VTAK, DYAI, TCBP
Via AB Newswire
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Closes $10M Private Offering Amid Investor Interest
Via AB Newswire
Market Momentum: Analyzing Five Stocks Exhibiting Strong Upward Trends: INBS, MEDS, IFBD, AISP, VTAK
Via AB Newswire
Intelligent Bio Solutions Inc (NASDAQ: INBS) Teams Up with Cliantha Research for FDA 510(k) Pathway Clinical Study
Via AB Newswire
Exploring Stocks with High Short Interest: INBS, BLNK, BYND, NVAX, PLUG
Via AB Newswire
Topics Electric Vehicles
Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI
Via AB Newswire
Breaking Ground in BioPharma: Spotlight Companies DYAI, INBS, SANA, IOVA, BLUE
Via AB Newswire
Top 5 Active Stock Buzzers Under $10: INBS, PLUG, KOPN, DYAI, MINM
Via AB Newswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.